These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15128361)

  • 1. Antidepressants in IBS: are we deluding ourselves?
    Talley NJ
    Am J Gastroenterol; 2004 May; 99(5):921-3. PubMed ID: 15128361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial.
    Tabas G; Beaves M; Wang J; Friday P; Mardini H; Arnold G
    Am J Gastroenterol; 2004 May; 99(5):914-20. PubMed ID: 15128360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome.
    Bundeff AW; Woodis CB
    Ann Pharmacother; 2014 Jun; 48(6):777-84. PubMed ID: 24651166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis.
    Xie C; Tang Y; Wang Y; Yu T; Wang Y; Jiang L; Lin L
    PLoS One; 2015; 10(8):e0127815. PubMed ID: 26252008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release.
    Han C; Masand PS; Krulewicz S; Peindl K; Mannelli P; Varia IM; Pae CU; Patkar AA
    J Clin Pharm Ther; 2009 Feb; 34(1):79-88. PubMed ID: 19125906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants for irritable bowel syndrome-A systematic review.
    Kułak-Bejda A; Bejda G; Waszkiewicz N
    Pharmacol Rep; 2017 Dec; 69(6):1366-1379. PubMed ID: 29132094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irritable bowel syndrome in psychiatric perspectives: a comprehensive review.
    Pae CU; Masand PS; Ajwani N; Lee C; Patkar AA
    Int J Clin Pract; 2007 Oct; 61(10):1708-18. PubMed ID: 17877658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
    Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
    J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of irritable bowel syndrome.
    Trinkley KE; Nahata MC
    J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to antidepressant discontinuation: a comparison of controlled-release paroxetine and immediate-release selective serotonin-reuptake inhibitors.
    Eaddy M; Bramley T; Regan T
    Manag Care Interface; 2003 Dec; 16(12):22-7. PubMed ID: 14750459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
    Tack J; Broekaert D; Fischler B; Van Oudenhove L; Gevers AM; Janssens J
    Gut; 2006 Aug; 55(8):1095-103. PubMed ID: 16401691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics as a possible treatment option for irritable bowel syndrome.
    Pae CU; Lee SJ; Han C; Patkar AA; Masand PS
    Expert Opin Investig Drugs; 2013 May; 22(5):565-72. PubMed ID: 23506326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of refractory irritable bowel syndrome with subclinical dosage of antidepressants].
    Wang WA; Qian JM; Pan GZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):74-8. PubMed ID: 12905614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.
    Ford AC; Talley NJ; Schoenfeld PS; Quigley EM; Moayyedi P
    Gut; 2009 Mar; 58(3):367-78. PubMed ID: 19001059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial.
    Talley NJ; Kellow JE; Boyce P; Tennant C; Huskic S; Jones M
    Dig Dis Sci; 2008 Jan; 53(1):108-15. PubMed ID: 17503182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.
    Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
    Am J Gastroenterol; 2014 Sep; 109(9):1350-65; quiz 1366. PubMed ID: 24935275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2008 Clinical approach to irritable bowel syndrome.
    Astegiano M; Pellicano R; Sguazzini C; Berrutti M; Simondi D; Reggiani S; Rizzetto M
    Minerva Gastroenterol Dietol; 2008 Sep; 54(3):251-7. PubMed ID: 18614974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome.
    Masand PS; Pae CU; Krulewicz S; Peindl K; Mannelli P; Varia IM; Patkar AA
    Psychosomatics; 2009; 50(1):78-86. PubMed ID: 19213976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common gastrointestinal symptoms: irritable bowel syndrome.
    Fashner J; Gitu AC
    FP Essent; 2013 Oct; 413():16-23. PubMed ID: 24124703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study.
    Kuiken SD; Tytgat GN; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2003 May; 1(3):219-28. PubMed ID: 15017494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.